NCT04988659

Brief Summary

Femoral acetabular impingement (FAI) is a common disease of the hip joint. In this study, whole-genome sequencing was used to further explore the pathogenesis of this disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2021

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

June 25, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 3, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

August 3, 2021

Status Verified

June 1, 2021

Enrollment Period

2 months

First QC Date

June 25, 2021

Last Update Submit

July 26, 2021

Conditions

Femoroacetabular Impingement

Outcome Measures

Primary Outcomes (1)

  • The patients were clinically diagnosed with FAI (femoral acetabular impingement) and underwent arthroscopic surgery, then clinical samples were collected.

    Peripheral blood from 100 patients with femoral acetabular impingement syndrome was collected and DNA was extracted.

    The patient was diagnosed with FAI, and conservative treatment was ineffective for an average of 6 months.

Interventions

ExposuresOTHER

Exposures

Eligibility Criteria

Age15 Years - 70 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Both patients were from Peking University Third Hospital and were diagnosed as Femoroacetabular impingement syndrome.

You may qualify if:

  • The patient underwent preoperative imaging and was diagnosed with FAI. The patient complained of pain in the hip, hip, or thigh, and had a positive hip flexion impact test.

You may not qualify if:

  • Patients with hip surgery history, hip osteoarthritis, necrosis of the femoral head, hip infection, hip dysplasia and other hip diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Peking University Third Hospital

Beijing, 100083, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral blood from 100 patients with femoral acetabular impingement (FAI) was collected and DNA was extracted.

MeSH Terms

Conditions

Femoracetabular Impingement

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • yan xu

    Peking University Third Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2021

First Posted

August 3, 2021

Study Start

March 30, 2021

Primary Completion

May 30, 2021

Study Completion

September 30, 2021

Last Updated

August 3, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)